The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor response and adaptation to CYP17 inhibition in prostate cancer: Induction of steroidogenesis and androgen receptor splice variants.
Elahe A. Mostaghel
No relevant relationships to disclose
Brett Marck
No relevant relationships to disclose
Alvin M. Matsumoto
No relevant relationships to disclose
Peter Nelson
No relevant relationships to disclose
Robert Vessella
No relevant relationships to disclose
Stephen R Plymate
No relevant relationships to disclose
Robert B. Montgomery
No relevant relationships to disclose